Menu
Subscribe to our Email Alerts
Home
About Us
Company Overview
Board of Directors
Management
Scientific Advisory Board
Corporate Directory
Corporate Governance
Pipeline
Background - FAK
Background - Fibrotic Cancers
Background - Fibrosis
Our FAK Inhibitors
Investor Information
Welcome
Investor Fact Sheet
Investor Presentations
Research Reports
Top 20 Shareholders
Shareholder Services
Investor FAQs
US Shareholders
Announcements and Reports
ASX Announcements
Annual Reports
Half Yearly Reports
Quarterly Reports
Contact Us
Contact Us
Email Alerts
Announcements and Reports
Home
>
Announcements and Reports
>
Half Yearly Reports
ASX Announcements
Annual Reports
Half Yearly Reports
Quarterly Reports
Half Yearly Reports
28-Nov-2018
Financial Report Half Year Ended 30 September 2018
